Xing Lyu

9PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPacific Peoples life coursePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 28, 2026
Association between elemental concentrations and chemotherapy-related acute adverse events in patients with nasopharyngeal carcinoma.

|Feb 10, 2026
Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial.

Xun Cao, Jia-Yu Zhou, Hao-Yang Huang

|May 19, 2025
Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial.

Xun Cao, Zhuo-Ying Luo, Hao-Yang Huang

|Aug 27, 2024
Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study.

Haoyang Huang, Yuping Zhao, Ying Deng

|Jan 31, 2024
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial.

Xun Cao, Hao-Yang Huang, Chi-Xiong Liang

|May 22, 2023
Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma.

Lu-Lu Zhang, Xi Chen, Ying-Ying Huang

Pageof 2

Frequent Collaborators

4 joint publications

Xi Chen

3 joint publications

Xun Cao

2 joint publications

Zejiang Zhan

2 joint publications

Lu-Lu Zhang